Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.39 |
| ▸ | PGR | P06401 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | BAX | Q07812 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17345797 | 0.91 | LTA4H (0.44) | LTA4HPGRLMNAFFAR1TSHR | |
| SCHEMBL17342250 | 0.79 | ALDH1A1 (0.44) | LTA4HLMNATSHRHPGDALDH1A1 | |
| SCHEMBL2574194 | 0.77 | MEN1 (0.42) | LMNATSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL16755617 | 0.74 | TDP1 (0.43) | HPGDMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL20021864 | 0.74 | TSHR (0.46) | LMNATSHRHPGDALDH1A1L3MBTL1 | |
| SCHEMBL20025824 | 0.74 | CYP2C19 (0.44) | LMNATSHRHPGDALDH1A1 | |
| SCHEMBL17342248 | 0.73 | NR1H3 (0.35) | NR1H2 | |
| SCHEMBL11725710 | 0.72 | TSHR (0.40) | PGRLMNATSHRSMN1; SMN2HPGD | |
| SCHEMBL11729000 | 0.72 | APP (0.39) | TSHRHPGDMEN1KMT2AALDH1A1 | |
| SCHEMBL24829502 | 0.69 | POLB (0.32) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9562062-B2 | Ligand compound, organic chromium compound, catalyst system for ethylene oligomerization, and method for ethylene oligomerization using the same | LG CHEM, LTD (KR) | 2017-02-07 | — | — | US | disclosed |
| US-20150361118-A1 | LIGAND COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLEFIN OLIGOMERIZATION USING THE SAME | LG CHEM, LTD. (KR) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361118-A1 | LIGAND COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLEFIN OLIGOMERIZATION USING THE SAME | OXER1, OSTC, OR51E2 | LTA4H 106/4885PGR 2172/4885LMNA 3426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.